BioPhy Awarded One of Fast Company’s 2024 World Changing Ideas
Uniquely deployable at any stage from pre-clinical through regulatory approval and beyond, BioPhy leverages robust data, pending patents, and world-renowned AI expertise to drive unprecedented speed and value from early-stage biotech to large pharmaceutical companies.
Philadelphia, PA, May 14, 2024 — The winners and honorees of Fast Company’s 2024 World Changing Ideas Awards were announced today, highlighting fresh sustainability initiatives, cutting-edge AI developments, ambitious pursuits of social equity, and other creative projects that are helping mold the world. BioPhy’s AI drug development platform was awarded one of Fast Company’s 2024 World Changing Ideas in the Science and Technology Category.
BioPhy is on a mission to develop therapies faster, better, and more affordably to positively impact patient lives. By pioneering AI innovation in drug development, we are permanently elevating productivity to address the alarming clinical success rates that result in 95% of drugs failing trials. Our AI democratization allows underfunded research teams to realize innovations that previously only large pharmaceutical companies could pursue, empowering revolutionary science.
BioPhy's AI benchmarks potential therapies to accurately assess viability, optimize trial design, and identify the highest potential programs to advance, resulting in significant cost savings, better therapies, and outsized investor funding. With expansions across pharmaceutical companies, BioPhy also accelerates AI for R&D, quality and GxP applications, clinical operations, and regulatory affairs to detect anomalies, avoid deviations, predict adverse events, evaluate commercial viability, providing billions in potential savings.
This year’s World Changing Ideas Awards was selected by a panel of Fast Company editors and reporters selected winners from a pool of more than 1,300 entries across climate, social justice, wellness, politics, technology, corporate social responsibility, and more. Several new categories were added this year, including beauty and fashion, health products, health services, materials, and science and technology. The 2024 awards feature entries from across the globe, including the Republic of Korea, Brazil, and Madagascar.
Fast Company’s Spring 2024 issue (on newsstands May 21, 2024) will unveil some of the world’s most creative minds and pioneering organizations that are seeking to disrupt the status quo, including BioPhy.
“BioPhy’s AI drug development platform provides a roadmap on how to identify and accelerate the developing of life-saving drugs for patients.” Said David Latshaw II, PhD, CEO. “The entire BioPhy team is truly honored to be recognized by Fast Company’s prestigious list of World Changing Ideas this year, it’s a major accomplishment to be regarded as one of today’s innovators and industry disruptors.”
“I was struck this year by the global sweep of the honorees,” says Fast Company editor-in-chief Brendan Vaughan. “It’s endlessly inspiring to see how the world is coming together to devise inventive solutions to our most challenging problems. We need ideas from everywhere, and this year’s World Changing Ideas Awards are an extraordinary encapsulation of the innovation and creativity that is so abundant around the globe.”
ABOUT BIOPHY
BioPhy is at the forefront of a new era in drug development, leveraging the synergistic power of its two groundbreaking AI technologies, BioLogicAI and BioPhyRx. These frontier solutions work in harmony to streamline the entire drug development process, post lead optimization to regulatory approval, ultimately bringing therapies to patients more efficiently and cost-effectively.
BioLogicAI harnesses the potential of a proprietary AI engine powered the industry's most extensive knowledge graph to provide unmatched insights and predictions. BioLogicAI can accurately assess the viability of potential therapies, optimize trial designs, and prioritize the most promising drug candidates. This not only saves valuable time and resources but also attracts significant investor interest.
Complementing BioLogicAI's capabilities, BioPhyRx is a purpose-built language system designed to address the specific needs of the drug development industry. BioPhyRx can complete function specific workflows in key areas of development. BioPhyRx overcomes the limitations of popular large language models, providing unparalleled transparency, accuracy, and domain-specific expertise.
The seamless integration of BioLogicAI and BioPhyRx has already demonstrated remarkable success across the pharmaceutical industry, from small biotech startups to global pharmaceutical companies and continues to expand.
For more information, please visit BioPhy.ai or connect with us on Linkedin.
ABOUT THE WORLD CHANGING IDEAS AWARDS: World Changing Ideas is one of Fast Company’s major annual awards programs and is focused on social good, seeking to elevate finished products and bold concepts that make the world better. Judges choose winners, finalists, and honorable mentions based on feasibility and the potential for impact. With the goals of awarding ingenuity and fostering innovation, Fast Company draws attention to ideas with great potential and helps them expand their reach to inspire more people to work on solving the problems that affect us all.
ABOUT FAST COMPANY
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.